Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Receivables (2016 - 2024)

Historic Receivables for Dare Bioscience (DARE) over the last 9 years, with Q4 2024 value amounting to $929982.0.

  • Dare Bioscience's Receivables changed N/A to $929982.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $929982.0, marking a year-over-year change of. This contributed to the annual value of $929982.0 for FY2024, which is N/A changed from last year.
  • Per Dare Bioscience's latest filing, its Receivables stood at $929982.0 for Q4 2024.
  • Over the past 5 years, Dare Bioscience's Receivables peaked at $52.0 million during Q2 2021, and registered a low of $282560.0 during Q3 2020.
  • Moreover, its 4-year median value for Receivables was $893852.0 (2020), whereas its average is $8.5 million.
  • As far as peak fluctuations go, Dare Bioscience's Receivables skyrocketed by 1499748.41% in 2021, and later tumbled by 7663.83% in 2022.
  • Over the past 4 years, Dare Bioscience's Receivables (Quarter) stood at $472168.0 in 2020, then surged by 142.57% to $1.1 million in 2021, then skyrocketed by 959.76% to $12.1 million in 2022, then crashed by 92.34% to $929982.0 in 2024.
  • Its Receivables stands at $929982.0 for Q4 2024, versus $12.1 million for Q2 2022 and $1.1 million for Q4 2021.